MICROBOT MEDICAL INC.

EDGAR

177 filing records in this dataset, filed from 1996-08-14 to 2026-10-27. Reported financial figures are available; chart coverage varies by period.

Watchlist

Latest quarter

Revenue

241 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Operating margin

-2,567.63%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -6188000 USD Source
  • Revenue: 241000 USD Source

Operating cash flow

-4.99 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -10042000 USD Source
  • Operating Cash Flow: -5053000 USD Source

Free cash flow

-5.13 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -10042000 USD Source
  • Operating Cash Flow: -5053000 USD Source
  • Capital Expenditure: 250000 USD Source
  • Capital Expenditure: 108000 USD Source
Cash and cash equivalents
3.15 million USD Source
Exact value

3152000 USD

Long-term debt including current maturities
Not available
Shares outstanding
67.2 million shares Source
Exact value

67164801 shares

Reported share-count change

76.94% · 29.2 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 37958316 shares · 2025-06-30· Source
  • 67164801 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-16.3 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: -3577000 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: -13142000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -9678000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -3671000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -5627000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-17.6 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -9288000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -5447000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -13046000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -9288000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -5053000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -10042000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -5053000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

288 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Capital expenditure: 35000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 22000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 60000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 35000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 108000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 250000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 108000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-17.9 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -9288000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -5447000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -13046000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -9288000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -5053000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -10042000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -5053000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 35000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 22000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 60000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 35000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 108000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 250000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 108000 USD · 2026-01-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-27.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 1 of 11 periods available· newest 2015-12-31
  • Operating income: 11 of 11 periods available· newest 2025-12-31
  • Net income: 11 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 11 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 11 of 11 periods available· newest 2025-12-31
  • Total assets: 11 of 11 periods available· newest 2025-12-31
  • Total liabilities: 11 of 11 periods available· newest 2025-12-31
  • Current assets: 11 of 11 periods available· newest 2025-12-31
  • Current liabilities: 11 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 1.7 million

    Prior period

    −USD 11.44 million

    –

    Current period

    −USD 13.14 million

    –

    Exact inputs and evidence

    -13142000 − -11443000 = -1699000 USD

    -11443000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -13142000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 4.22 million

    Prior period

    −USD 8.83 million

    –

    Current period

    −USD 13.05 million

    –

    Exact inputs and evidence

    -13046000 − -8827000 = -4219000 USD

    -8827000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -13046000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +140%

    Prior period

    USD 25,000

    –

    Current period

    USD 60,000

    –

    Exact inputs and evidence

    60000 − 25000 = 35000 USD

    25000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    60000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 116.9K 2015
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.126.2K94.7K63.1K31.6K0.02015
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Revenue116887

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2015Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 782.8% 2015
Net margin -787.9% 2015
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.908%453%-3%-458%-914%2015
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2015Operating margin782.8%
2015Net margin-787.9%
2015Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Operating cash flowNot reportedNo source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Free cash flowUnavailableNo source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

79.2% 2015
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.86%64%43%21%0%2015
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2015Liabilities / assets79.2%

Current assets to current liabilities

Current assets divided by current liabilities.

2.82× 2015
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.05×2.29×1.52×0.76×0.00×2015
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2015Current assets / current liabilities2.82×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2016-01-01 – 2016-12-31
−USD 9.66 million
Exact value

Exact value: -9663000 USD

2016-01-01 – 2016-12-31: -9663000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 786,000
Exact value

Exact value: -786000 USD

2016-01-01 – 2016-12-31: -786000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 25,000
Exact value

Exact value: 25000 USD

2016-01-01 – 2016-12-31: 25000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 811,000
Calculation and evidence

-786000 − 25000 USD

Exact free cash flow: -811000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2017-01-01 – 2017-12-31
−USD 7.59 million
Exact value

Exact value: -7589000 USD

2017-01-01 – 2017-12-31: -7589000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 4.86 million
Exact value

Exact value: -4856000 USD

2017-01-01 – 2017-12-31: -4856000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 58,000
Exact value

Exact value: 58000 USD

2017-01-01 – 2017-12-31: 58000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 4.91 million
Calculation and evidence

-4856000 − 58000 USD

Exact free cash flow: -4914000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
−USD 7.26 million
Exact value

Exact value: -7260000 USD

2018-01-01 – 2018-12-31: -7260000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 5.31 million
Exact value

Exact value: -5310000 USD

2018-01-01 – 2018-12-31: -5310000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 223,000
Exact value

Exact value: 223000 USD

2018-01-01 – 2018-12-31: 223000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 5.53 million
Calculation and evidence

-5310000 − 223000 USD

Exact free cash flow: -5533000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 7.25 million
Exact value

Exact value: -7247000 USD

2019-01-01 – 2019-12-31: -7247000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 6.45 million
Exact value

Exact value: -6451000 USD

2019-01-01 – 2019-12-31: -6451000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 216,000
Exact value

Exact value: 216000 USD

2019-01-01 – 2019-12-31: 216000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 6.67 million
Calculation and evidence

-6451000 − 216000 USD

Exact free cash flow: -6667000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 9.17 million
Exact value

Exact value: -9169000 USD

2020-01-01 – 2020-12-31: -9169000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 7.25 million
Exact value

Exact value: -7252000 USD

2020-01-01 – 2020-12-31: -7252000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 91,000
Exact value

Exact value: 91000 USD

2020-01-01 – 2020-12-31: 91000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 7.34 million
Calculation and evidence

-7252000 − 91000 USD

Exact free cash flow: -7343000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 11.31 million
Exact value

Exact value: -11313000 USD

2021-01-01 – 2021-12-31: -11313000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.35 million
Exact value

Exact value: -9354000 USD

2021-01-01 – 2021-12-31: -9354000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 69,000
Exact value

Exact value: 69000 USD

2021-01-01 – 2021-12-31: 69000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.42 million
Calculation and evidence

-9354000 − 69000 USD

Exact free cash flow: -9423000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 13.17 million
Exact value

Exact value: -13168000 USD

2022-01-01 – 2022-12-31: -13168000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 11.55 million
Exact value

Exact value: -11549000 USD

2022-01-01 – 2022-12-31: -11549000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 84,000
Exact value

Exact value: 84000 USD

2022-01-01 – 2022-12-31: 84000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 11.63 million
Calculation and evidence

-11549000 − 84000 USD

Exact free cash flow: -11633000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 10.74 million
Exact value

Exact value: -10740000 USD

2023-01-01 – 2023-12-31: -10740000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.53 million
Exact value

Exact value: -8533000 USD

2023-01-01 – 2023-12-31: -8533000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 33,000
Exact value

Exact value: 33000 USD

2023-01-01 – 2023-12-31: 33000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.57 million
Calculation and evidence

-8533000 − 33000 USD

Exact free cash flow: -8566000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 11.44 million
Exact value

Exact value: -11443000 USD

2024-01-01 – 2024-12-31: -11443000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.83 million
Exact value

Exact value: -8827000 USD

2024-01-01 – 2024-12-31: -8827000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 25,000
Exact value

Exact value: 25000 USD

2024-01-01 – 2024-12-31: 25000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.85 million
Calculation and evidence

-8827000 − 25000 USD

Exact free cash flow: -8852000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 13.14 million
Exact value

Exact value: -13142000 USD

2025-01-01 – 2025-12-31: -13142000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 13.05 million
Exact value

Exact value: -13046000 USD

2025-01-01 – 2025-12-31: -13046000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 60,000
Exact value

Exact value: 60000 USD

2025-01-01 – 2025-12-31: 60000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 13.11 million
Calculation and evidence

-13046000 − 60000 USD

Exact free cash flow: -13106000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

177 filings · 3,500 latest values · 3,500 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0000883975, 883975, MBOT, STEM, edgar:883975

Also known as CYTOTHERAPEUTICS INC/DE, MICROBOT MEDICAL INC., MICROBOT MEDICAL INC., MICROBOT MEDICAL INC, MICROBOT MEDICAL INC., Microbot Medical Inc., STEMCELLS INC